Craniometaphyseal dysplasia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Craniometaphyseal dysplasia
Synonyms	CMD
Pronounce
Specialty	Medical genetics
Symptoms	Facial dysmorphism, cranial nerve compression, hearing loss, vision problems
Complications	Blindness, deafness, breathing difficulties
Onset	Childhood
Duration	Lifelong
Types	Autosomal dominant, autosomal recessive
Causes	Genetic mutation
Risks	Family history
Diagnosis	Clinical evaluation, radiographic imaging, genetic testing
Differential diagnosis	Osteopetrosis, Paget's disease of bone
Prevention	Genetic counseling
Treatment	Surgery, physical therapy, hearing aids
Medication
Prognosis	Variable, depends on severity
Frequency	Rare
Deaths	Rarely life-threatening

Craniometaphyseal Dysplasia

X-ray showing the characteristic features of Craniometaphyseal Dysplasia. Craniometaphyseal dysplasia (CMD) is a rare genetic disorder that affects the bones of the skull and the long bones of the body. It is characterized by abnormal bone growth, particularly in the cranial and metaphyseal regions. This condition can lead to various complications, including facial deformities, hearing loss, and neurological problems.

Signs and Symptoms

The signs and symptoms of Craniometaphyseal dysplasia can vary widely among affected individuals. However, some common features include: - Progressive thickening of the bones in the skull and facial region, leading to facial deformities such as a broadened nose, wide-set eyes, and an enlarged jaw. - Hearing loss, which can range from mild to severe. - Neurological symptoms, including headaches, vision problems, and difficulty with coordination. - Dental abnormalities, such as delayed tooth eruption and overcrowding of teeth. - Bone abnormalities in the long bones, which can cause pain, fractures, and limited mobility.

Causes

Craniometaphyseal dysplasia is caused by mutations in the ANKH gene, which is responsible for producing a protein involved in the regulation of bone growth and mineralization. These mutations disrupt the normal function of the protein, leading to abnormal bone growth and remodeling. This condition follows an autosomal dominant pattern of inheritance, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the disorder. In some cases, however, Craniometaphyseal dysplasia can occur sporadically, without a family history of the condition.

Diagnosis

Diagnosing Craniometaphyseal dysplasia typically involves a combination of clinical evaluation, imaging studies, and genetic testing. X-rays and CT scans can reveal the characteristic thickening of the bones in the skull and long bones. Genetic testing can confirm the presence of mutations in the ANKH gene.

Treatment

Currently, there is no cure for Craniometaphyseal dysplasia. Treatment is focused on managing the symptoms and complications associated with the condition. This may involve a multidisciplinary approach, including the involvement of orthopedic surgeons, otolaryngologists, and dentists. Treatment options may include: - Medications to manage pain and reduce bone overgrowth. - Surgical interventions to relieve pressure on the cranial nerves, improve hearing, or correct facial deformities. - Dental interventions to address overcrowding or other dental abnormalities. - Assistive devices, such as hearing aids or mobility aids, to improve quality of life.

Prognosis

The prognosis for individuals with Craniometaphyseal dysplasia can vary depending on the severity of the condition and the specific complications present. Some individuals may experience relatively mild symptoms and have a normal lifespan, while others may have more severe symptoms and a reduced life expectancy. Regular monitoring and management of symptoms are essential to optimize the quality of life for individuals with Craniometaphyseal dysplasia.

See Also

• Genetic disorder
• Bone abnormalities
• Osteogenesis imperfecta

References

1. GeneReviews: Craniometaphyseal Dysplasia. National Center for Biotechnology Information. Retrieved from [1]. 2. Craniometaphyseal Dysplasia. National Organization for Rare Disorders. Retrieved from [2].